Consonance Capital Management’s Medicus Sciences Acquisition Corp. Class A Ordinary Share MSAC Stock Holding History

Consonance Capital Management’s Portfolio MSAC Stock Details MSAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-300,000	Closed	-$2.92M	–	12
2021 Q4	$2.92M	Hold	300,000	–	–	1.9%	9
2021 Q3	$2.92M	Hold	300,000	–	–	1.6%	10
2021 Q2	$2.9M	Buy	+300,000	New	+$2.93M	0.35%	24

Other funds holding MSAC

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Consonance Capital Management's MSAC Position: Q1 2022 in Review

Consonance Capital Management sold out of Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) in Q1 2022, closing a stake of 300,000 shares — an estimated $2.92M sold.

Consonance Capital Management first reported a position in MSAC in Q2 2021 and held it in 3 quarters. The position peaked at $2.92M in Q3 2021. 54 funds tracked by Wall St. Rank hold MSAC as of Q1 2022.

Consonance Capital Management reported no remaining Medicus Sciences Acquisition Corp. Class A Ordinary Share position as of Q1 2022 after selling out during the quarter.
Consonance Capital Management sold 300,000 Medicus Sciences Acquisition Corp. Class A Ordinary Share shares in Q1 2022, an estimated $2.92M.
Consonance Capital Management first reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share in Q2 2021 and held it in 3 quarters.
Consonance Capital Management's Medicus Sciences Acquisition Corp. Class A Ordinary Share position peaked at $2.92M in Q3 2021.
54 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Class A Ordinary Share as of Q1 2022.

Based on Consonance Capital Management's 13F filing for Q1 2022, filed 16 May 2022.